Conventional radiography and correlated factors of enthesopathies of the Achilles tendon and plantar fascia in patients with axial spondyloarthritis

Ebru Yılmaz; Özge Pasin; Loiane Cristina de Souza; Guilherme Torres Vilarino; Alexandro Andrade; Camila Gusmão Vicente de Carvalho; Barbara Bayeh; Fernando Henrique Carlos de Souza; Renata Miossi; Pleiades Tiharu Inaoka; Takashi Matsushita; Naoki Mugii; Samuel Katsuyuki Shinjo; M. Rossini; O Viapiana; G. Orsolini; E. Fracassi; L. Idolazzi; D. Gatti; S. Adami; M. Govoni

doi:10.4081/reumatismo.2024.1709

Reviews Open access

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?

Authors

M. Rossini – articles in this journal Corresponding author Email Rheumatology Unit, University of Verona, Italy.
O Viapiana – articles in this journal Rheumatology Unit, University of Verona, Italy.
G. Orsolini – articles in this journal Rheumatology Unit, University of Verona, Italy.
E. Fracassi – articles in this journal Rheumatology Unit, University of Verona, Italy.
L. Idolazzi – articles in this journal Rheumatology Unit, University of Verona, Italy.
D. Gatti – articles in this journal Rheumatology Unit, University of Verona, Italy.
S. Adami – articles in this journal Rheumatology Unit, University of Verona, Italy.
M. Govoni – articles in this journal Rheumatology Unit, University of Ferrara, Italy.

Published: 31 March 2015
Issue: Vol. 66 No. 4 (2014)
Section: Reviews
DOI: 10.4081/reumatismo.2014.799
Pages: 285-303

Abstract

Golimumab is an anti-TNF monoclonal antibody administred subcutaneously once a month and produced with an innovative technology that minimizes immunogenicity. This paper reviews and updates the main studies on the efficacy, safety and pharmacoeconomic aspects of treatment with golimumab of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis.

Keywords

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.

License

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.

Downloads

PDF

Article history

Received: 12 October 2014
Accepted: 22 December 2014
Published: 31 March 2015

Article statistics

2,966abstract views

2,495PDF

Smart Citations (scite.ai)

How to Cite

1.

Rossini M, Viapiana O, Orsolini G, Fracassi E, Idolazzi L, Gatti D, et al. Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis? Reumatismo [Internet]. 2015 Mar. 31 [cited 2026 Nov. 8];66(4):285-303. Available from: https://www.reumatismo.org/reuma/article/view/reumatismo.2014.799

Download Citation

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Submit your article

Read the guidelines for authors before you start your submission.

Make a Submission